This Regulation lays down detailed procedural rules for joint scientific consultations carried out pursuant to Articles 16 to 21 of Regulation (EU) 2021/2282, as regards:
submission of requests from health technology developers for joint scientific consultations on medical devices and in vitro diagnostic medical devices;
the selection and consultation of stakeholder organisations and patients, clinical experts and other relevant experts (‘individual experts’) in joint scientific consultation on medical devices and in vitro diagnostic medical devices;
cooperation, in particular by exchange of information, with the expert panels on joint scientific consultations on medical devices where a health technology developer requests the consultation to be carried out in parallel with the expert panel consultation pursuant to Article 17(2) of Regulation (EU) 2021/2282 (‘the expert panel consultation’).